These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27726804)

  • 21. Induction of transplantation tolerance through regulatory cells: from mice to men.
    Ferrer IR; Hester J; Bushell A; Wood KJ
    Immunol Rev; 2014 Mar; 258(1):102-16. PubMed ID: 24517428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
    Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
    PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells in renal transplantation and modulation by immunosuppression.
    López-Hoyos M; Segundo DS; Fernández-Fresnedo G; Marín MJ; González-Martín V; Arias M
    Transplantation; 2009 Aug; 88(3 Suppl):S31-9. PubMed ID: 19667959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.
    Gharagozloo M; Majewski S; Foldvari M
    Nanomedicine; 2015 May; 11(4):1003-18. PubMed ID: 25596076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?
    Demirkiran A; Hendrikx TK; Baan CC; van der Laan LJ
    Transplantation; 2008 Mar; 85(6):783-9. PubMed ID: 18360256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
    Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
    J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in Costimulatory Blockade to Induce Immune Tolerance in Liver Transplantation.
    Ding M; He Y; Zhang S; Guo W
    Front Immunol; 2021; 12():537079. PubMed ID: 33732228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
    Wolfraim LA
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
    Gonzalez-Rey E; Anderson P; Delgado M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control and prevention of kidney transplant rejection: the role and possibilities for the clinical use of regulatory T-cells in transplantation].
    Mukhin VE; Polyakova YV; Kaabak MM; Babenko NN; Bryzgalina EV; V'yunkova YN
    Khirurgiia (Mosk); 2019; (9):80-85. PubMed ID: 31532171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
    Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
    Magee CN; Murakami N; Borges TJ; Shimizu T; Safa K; Ohori S; Cai S; Uffing A; Azzi J; Elyaman W; Charbonnier LM; Liu K; Toprak D; Visner G; Chatila TA; Siebel CW; Najafian N; Riella LV
    Circulation; 2019 Sep; 140(10):846-863. PubMed ID: 31266349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune privilege induced by regulatory T cells in transplantation tolerance.
    Cobbold SP; Adams E; Graca L; Daley S; Yates S; Paterson A; Robertson NJ; Nolan KF; Fairchild PJ; Waldmann H
    Immunol Rev; 2006 Oct; 213():239-55. PubMed ID: 16972908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costimulatory molecules as targets for the induction of transplantation tolerance.
    Alegre ML; Najafian N
    Curr Mol Med; 2006 Dec; 6(8):843-57. PubMed ID: 17168736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From current immunosuppressive strategies to clinical tolerance of allografts.
    Golshayan D; Buhler L; Lechler RI; Pascual M
    Transpl Int; 2007 Jan; 20(1):12-24. PubMed ID: 17181648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.
    Cobbold SP
    Immunotherapy; 2009 May; 1(3):447-60. PubMed ID: 20635961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
    LaMothe RA; Kolte PN; Vo T; Ferrari JD; Gelsinger TC; Wong J; Chan VT; Ahmed S; Srinivasan A; Deitemeyer P; Maldonado RA; Kishimoto TK
    Front Immunol; 2018; 9():281. PubMed ID: 29552007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.
    Zhang W; Zhang D; Shen M; Liu Y; Tian Y; Thomson AW; Lee WP; Zheng XX
    J Immunol; 2010 Oct; 185(8):4750-9. PubMed ID: 20844194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.